Tafamidis meglumine (trade name: Vyndaqel) was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder ("orphan disease") is caused by a defective gene and is associated with ...
Sep 17, 2012
0
0
European researchers are working toward restoration of mobility in neuromuscular disease and trauma. Using miniature scaffolds to guide nerve regeneration, they are seeking to ensure proper functional connections between ...
Jul 31, 2012
0
0
Scientists at Washington University School of Medicine in St. Louis have shown that a protein may help prevent the kind of brain damage that occurs in babies with cerebral palsy.
Nov 2, 2011
0
0
